Burning Rock Biotech (BNR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov21

Burning Rock Biotech released FY2025 Q3 earnings on November 20 (EST), actual revenue USD 18.49 M, actual EPS USD -0.2184

04:00

Burning Rock Biotech released FY2025 9 Months Earnings on November 20 (EST), with actual revenue of USD 57.52 M and EPS of USD -0.5167

04:00

Sep24

Burning Rock's OncoScreen™ Plus CDx System Approved in Japan for Breast Cancer Treatment

05:57

Sep9

Burning Rock Biotech released FY2025 Q2 earnings on September 8, 2025 (EST), with actual revenue of USD 20.71 M and EPS of USD -0.1256

03:00

Burning Rock Biotech released FY2025 Semi-Annual earnings on September 8 (EST) with actual revenue of USD 39.02 M and EPS of USD -0.2986

03:00

Jun12

Burna Biotechnology's Stock Soars with Approval of Lung Cancer Companion Diagnostic

15:41

Schedules & Filings

Schedules

Filings

Nov20

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 18.49 M, Net Income -2.354 M, EPS -0.2184

Sep8

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 20.71 M, Net Income -1.353 M, EPS -0.1256

Jun6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 18.32 M, Net Income -1.859 M, EPS -0.1726

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More